A detailed history of Arvest Investments, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Arvest Investments, Inc. holds 11,244 shares of ABBV stock, worth $2.25 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
11,244
Previous 11,130 1.02%
Holding current value
$2.25 Million
Previous $1.91 Billion 16.31%
% of portfolio
0.34%
Previous 0.31%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $18,677 - $22,723
114 Added 1.02%
11,244 $2.22 Billion
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $10,835 - $12,653
-70 Reduced 0.63%
11,130 $1.91 Billion
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $37,238 - $42,429
-233 Reduced 2.04%
11,200 $2.04 Billion
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $1.57 Million - $1.77 Million
11,433 New
11,433 $1.77 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Arvest Investments, Inc. Portfolio

Follow Arvest Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Arvest Investments, Inc. with notifications on news.